Document Detail


Portal vein thrombosis: should anticoagulation be used?
MedLine Citation:
PMID:  23314804     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Portal vein thrombosis (PVT) can contribute to significant morbidity and mortality; in patients with cirrhosis, this can make transplant more technically challenging. Additionally, the clot may extend further into the mesenteric and splenic veins, and disturbance of the hepatic blood flow may lead to faster progression of the cirrhosis. Development of PVT is associated with local risk factors, and many patients have associated systemic prothrombotic factors. Anticoagulation in noncirrhotic patients should be initiated at diagnosis, using low-molecular-weight heparin overlapping with vitamin K antagonists. Cirrhotic patients with PVT should be screened for varices and then anticoagulated with low-molecular-weight heparin for at least a 6-month period. All patients should be assessed for triggering factors and tumors, as well as systemic prothrombotic factors. Newer evidence suggests that prophylactic anticoagulation in patients with cirrhosis may have a role in clinical management with decreased incidence of PVT and improved survival; further study is needed.
Authors:
Stephen E Congly; Samuel S Lee
Related Documents :
22848864 - A q-methodology study of patients' subjective experiences of tia.
2202954 - Patient controlled analgesia and gi dysfunction.
9693894 - Does interpleural bupivacaine blockade reduce arterial hypoxemia and pain in endoscopic...
6137954 - Follow-up of hydration and sedation in the pretherapy of premature labor.
3048054 - Inequalities in chronic dialysis and transplantation in sweden.
18996764 - Bariatric surgery in medicare patients: greater risks but substantial benefits.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current gastroenterology reports     Volume:  15     ISSN:  1534-312X     ISO Abbreviation:  Curr Gastroenterol Rep     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888896     Medline TA:  Curr Gastroenterol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  306     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of Calgary Liver Unit, 3330 Hospital Drive NW, Calgary, AB, Canada, T2N 4N1.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  An update on the hepatitis e virus.
Next Document:  Treatment of hepatitis C: how will we use viral kinetics, response-guided therapy?